Home/Filings/4/0001209191-22-021464
4//SEC Filing

Murphy Amanda Louise 4

Accession 0001209191-22-021464

CIK 0001287098other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 4:16 PM ET

Size

5.6 KB

Accession

0001209191-22-021464

Insider Transaction Report

Form 4
Period: 2022-03-25
Murphy Amanda Louise
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-03-25+142,000142,000 total
    Exercise: $7.12Exp: 2032-03-24Common Stock (142,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date.

Issuer

MAXCYTE, INC.

CIK 0001287098

Entity typeother

Related Parties

1
  • filerCIK 0001875169

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:16 PM ET
Size
5.6 KB